Acadian Asset Management LLC increased its holdings in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 118.2% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,196 shares of the company’s stock after purchasing an additional 2,815 shares during the period. Acadian Asset Management LLC’s holdings in Azenta were worth $273,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Norges Bank purchased a new position in Azenta in the 4th quarter worth approximately $140,856,000. Schroder Investment Management Group raised its holdings in Azenta by 14.6% during the 4th quarter. Schroder Investment Management Group now owns 625,515 shares of the company’s stock valued at $40,746,000 after buying an additional 79,913 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in Azenta by 5.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,115,816 shares of the company’s stock valued at $58,714,000 after buying an additional 56,387 shares during the period. Edgestream Partners L.P. grew its holdings in Azenta by 618.2% in the 1st quarter. Edgestream Partners L.P. now owns 58,644 shares of the company’s stock worth $3,535,000 after acquiring an additional 50,479 shares during the last quarter. Finally, Lighthouse Investment Partners LLC purchased a new position in shares of Azenta in the fourth quarter valued at about $1,973,000. Institutional investors own 99.08% of the company’s stock.
Azenta Trading Up 0.3 %
NASDAQ:AZTA opened at $49.50 on Friday. The company has a 50-day moving average price of $52.52 and a 200-day moving average price of $54.16. The stock has a market cap of $2.67 billion, a price-to-earnings ratio of -18.27 and a beta of 1.47. Azenta, Inc. has a 12 month low of $44.00 and a 12 month high of $69.16.
Analysts Set New Price Targets
AZTA has been the subject of a number of analyst reports. Evercore ISI increased their target price on shares of Azenta from $52.00 to $53.00 and gave the stock an “in-line” rating in a report on Tuesday, July 2nd. Needham & Company LLC reaffirmed a “buy” rating and set a $69.00 price target on shares of Azenta in a research report on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $67.00.
View Our Latest Report on AZTA
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
See Also
- Five stocks we like better than Azenta
- What is the Dow Jones Industrial Average (DJIA)?
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.